… Substantial efforts have been exerted to identify this subset of patients with a poor prognosis
at the time of diagnosis and several promising prognostic markers have been identified. …

Objective At 5 years' follow-up of early (<6 months) rheumatoid arthritis patients to (1) investigate
whether initial combination therapy with methotrexate (MTX) and ciclosporin (CSA) (n=…

Objective To investigate whether disease control can be achieved in early active rheumatoid
arthritis (RA) by treatment with methotrexate and intraarticular betamethasone, and whether …

Objective: To investigate whether clinical and radiographic disease control can be achieved
and maintained in patients with early, active rheumatoid arthritis (RA) during the second …

Objective To investigate the short-term and long-term efficacy of intra-articular betamethasone
injections, and the impact of joint area, repeated injections, MRI pathology, anticyclic …

Interleukin (IL)-6, a key player in the inflammatory response, may be a useful biomarker in
rheumatoid arthritis (RA). The aim was to determine analytical variability, a reference interval …

Serum YKL-40 is a potential biomarker of prognosis in cancer patients, but assessment of
serum YKL-40 requires knowledge of its normal variation. In this study, we evaluated diurnal, …

Mannan‐binding lectin (MBL) and MBL‐associated serine protease 2 (MASP‐2) are central
components of the MBL pathway of complement activation, and may have potential as …

Background: Soluble vascular endothelial growth factor (VEGF) is a promising biomarker in
monitoring rheumatoid arthritis (RA), but studies of pre-analytical and biologic variability are …

Galectin‐3 has been suggested as a pro‐inflammatory mediator in animal arthritis and
rheumatoid arthritis ( RA ). We aimed to study the serum level of galectin‐3 in patients with newly …